http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020000834-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40
filingDate 2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4623cd51b2cc2d917340818de35f35a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42663a1431783dcbd1b0b523edc63514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0691c86fba44b5a3b814750585eef573
publicationDate 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020000834-A
titleOfInvention DERIVATIVE OF ADAMANTYLMETHYLAMINE AND USE OF THE SAME AS A PHARMACEUTICAL PRODUCT.
abstract The present invention provides a pharmaceutical composition for the treatment or prevention of diseases or disorders of cognitive function, wherein the pharmaceutical composition contains a compound represented by formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
priorityDate 2017-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420120423

Total number of triples: 66.